Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Inv. presentation
Capstone Therapeutics Corp. (CAPS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2013 8-K Quarterly results
Docs: "Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results",
"Capstone Therapeutics Operating Update, August 14, 2013"
03/14/2013 8-K Quarterly results
Docs: "Capstone Therapeutics Will Provide an Operating Update and Announces 2012 Financial Results",
"Capstone Therapeutics Operating Update, March 14, 2013"
11/08/2012 8-K Quarterly results
Docs: "Capstone Therapeutics Will Provide an Operating Update and Announces Third Quarter 2012 Financial Results",
"Capstone Therapeutics Operating Update, November 8, 2012"
11/10/2010 8-K Quarterly results
Docs: "Capstone Therapeutics Announces Third Quarter 2010 Financial Results Tempe, AZ – November 10, 2010 ─ Capstone Therapeutics ; formerly OrthoLogic Corp.; , today announced financial results for the third quarter of 2010. The Company reported a net loss of $2.6 million, or $0.06 per share, for the third quarter of 2010, compared to a net loss of $3.3 million or $0.08 per share for the third quarter of 2009. The Company incurred a net loss in the nine months ended September 30, 2010 of $8.5 million or $0.21 per share, compared to a net loss of $10.6 million or $0.26 per share in the same period in 2009. The $2.1 million decrease in the net loss for the nine months ended September 30, 2010 compared to the same period in 2009 resulted primarily from the purchase in 2009 of peptide for pre-..."
08/09/2010 8-K Form 8-K - Current report
11/09/2009 8-K Quarterly results
Docs: "Capstone Therapeutics Announces Third Quarter 2009 Financial Results Tempe, AZ – November 9, 2009 ─ Capstone Therapeutics , trade name of OrthoLogic Corp. , today announced financial results for the third quarter 2009. The Company reported a net loss of $3.3 million, or $0.08 per share, for the third quarter 2009, compared to a net loss of $3.1 million or $0.08 per share for the third quarter 2008. The Company incurred a net loss in the nine months ended September 30, 2009 of $10.6 million compared to a net loss of $8.6 million in the same period in 2008. The $2 million increase in net loss for the nine months ended September 30, 2009 compared to the same period in 2008 resulted primarily from an increase in AZX100 clinical trial activity, purchases of peptide for pre-clinical studie..."
08/12/2009 8-K Form 8-K - Current report
05/11/2009 8-K Quarterly results
Docs: "Capstone Therapeutics Announces First Quarter 2009 Financial Results Tempe, AZ – May 11, 2009 ─ Capstone Therapeutics , trade name of OrthoLogic Corp. , today announced financial results for the first quarter 2009. The Company reported a net loss of $4.1 million, or $0.10 per share, for the first quarter 2009, compared to a net loss of $2.7 million or $0.06 per share for the first quarter 2008. The increase in net loss for the three months ended March 31, 2009 compared to the same period in 2008 resulted primarily from an increase in AZX100 clinical trial activity, purchases of peptide for pre-clinical studies, reduced interest income due to the decrease in interest rates between the two periods and reduction in the amount available for investment. The Company ended the first quarter..."
11/06/2008 8-K Quarterly results
Docs: "CAPSTONE THERAPEUTICS ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS"
08/07/2008 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES SECOND QUARTER 2008 FINANCIAL RESULTS"
05/07/2008 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES FIRST QUARTER 2008 FINANCIAL RESULTS AND CONFERENCE CALL"
03/05/2008 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES YEAR END 2007 OPERATING RESULTS AND STOCK REPURCHASE PROGRAM"
11/05/2007 8-K Quarterly results
Docs: "OrthoLogic Announces Third Quarter 2007 Financial Results"
08/08/2007 8-K Quarterly results
Docs: "OrthoLogic Announces Second Quarter 2007 Financial Results"
03/14/2007 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES YEAR END 2006 FINANCIAL RESULTS"
11/02/2006 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES THIRD QUARTER 2006 FINANCIAL RESULTS TEMPE, AZ — November 2, 2006 — OrthoLogic Corp. today announced financial results for the third quarter of 2006. OrthoLogic reported a net loss of $5.8 million, or $0.14 per share, for the third quarter of 2006, compared to a net loss of $7.6 million or $0.20 per share, for the third quarter of 2005. For the nine months ending September 30, 2006, net loss was $28.8 million, or $0.71 per share versus a net loss of $19.7 million or $0.52 per share for the nine months ended September 30, 2005. The results for the three months ended September 30, 2006 include stock based compensation expense of $0.6 million and recognition of a Chrysalin Product Platform patent impairment loss of $2.1 million. The results for the nine months ended Septe..."
08/09/2006 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES SECOND QUARTER 2006 FINANCIAL RESULTS TEMPE, AZ — August 9, 2006 — OrthoLogic Corp. today announced financial results for the second quarter of 2006. OrthoLogic reported a net loss of $6.5 million, or $0.16 per share, for the second quarter of 2006, compared to a net loss of $6.6 million or $0.17 per share for the second quarter of 2005. For the six months ended June 30, 2006 the net loss was $23.0 million, or $0.58 per share, versus a net loss of $12.1 million, or $0.32 per share, for the six months ended June 30, 2005. The increase in net loss for the six month period resulted from $8.4 million of in-process research and development costs related to the AzERx acquisition, the inclusion in 2006 of $1.7 million in non-cash stock compensation expense related to the Janu..."
05/04/2006 8-K Quarterly results
Docs: "ORTHOLOGIC ANNOUNCES FIRST QUARTER 2006 FINANCIAL RESULTS TEMPE, AZ — May 4, 2006 — OrthoLogic Corp. today announced financial results for the first quarter of 2006. OrthoLogic reported a net loss of $16.5 million, or $0.42 per share, for the first quarter of 2006, compared to a net loss of $5.5 million and $0.14 per share for the first quarter of 2005. Comparability between periods was affected by the inclusion in 2006 of $8.4 million of purchased in-process research and development costs related to the AzERx acquisition, $1 million in non-cash stock compensation costs associated with the adoption of SFAS123 effective January 1, 2006 and increased research and development costs resulting from a greater number of active subjects in the Chrysalin Phase 3 and Phase 2b fracture repair human c..."
01/31/2006 8-K Quarterly results
Docs: "OrthoLogic Corp. Stern Investor Relations, Inc. Les Taeger Melanie Friedman Chief Financial Officer 362-1200 286-5414 OrthoLogic Reports Fourth Quarter and Full-Year 2005 Results"
10/27/2005 8-K Quarterly results
Docs: "Employment Agreement, between the Company and Dana Shinbaum",
"Intellectual Property, Confidentiality and Non-Competition Agreement, between the Company and Dana Shinbaum",
"OrthoLogic Reports Third Quarter 2005 Results",
"Transcript of October 25, 2005 conference call"
07/26/2005 8-K Quarterly results
Docs: "OrthoLogic Reports Second Quarter 2005 Results"
05/10/2005 8-K Quarterly results
Docs: "OrthoLogic Reports First Quarter 2005 Results Company Announces Completion of Patient Enrollment for Pivotal Phase 3 Trial of Chrysalin for Acceleration of Fracture Repair"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy